Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.

Subjects

Subjects :

Humans
Glucagon-Like Peptide 1
Peptide Fragments
Liver
Non-alcoholic Fatty Liver Disease complications
Non-alcoholic Fatty Liver Disease drug therapy
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 drug therapy

Details

Language :

English

ISSN :

1463-1326

Volume :

26

Issue :

2

Database :

MEDLINE

Journal :

Diabetes, obesity & metabolism

Publication Type :

Report

Accession number :

37975640

Full Text :

https://doi.org/10.1111/dom.15359